So they knew CF33 isn't going to cut it mid last year before the interim clinical update was released 3 months later which was excellent so early in Ph1 (even @Mason14 reluctantly admitted they were excellent lol)???? What are you smoking???? And Azer-Cel (sic) is another cancer market which they didn't have access to previously.
